Clinical Trials Directory

Trials / Completed

CompletedNCT04004949

the Effect of Scapular Dyskinesia on the Scapular Balance Angle & Upper Extremity Sensorimotor Function in Spastic Stroke Patient. The Patients Were Diagnosed With the Lateral Scapular Slide Test, Fugl-Meyer Upper Extremity (FMUE) Scale Scores & Scapular Balance Angle Test (SBA).

The Effect of Scapular Dyskinesia on the Scapular Balance Angle & Upper Extremity Sensorimotor Function in Stroke Patients With Spasticity

Status
Completed
Phase
Study type
Observational
Enrollment
60 (actual)
Sponsor
Lama Saad El-Din Mahmoud · Academic / Other
Sex
All
Age
35 Years – 50 Years
Healthy volunteers
Not accepted

Summary

to investigate the effect of Scapular dyskinesia on the scapular balance angle \& upper extremity Sensorimotor Function in spastic stroke patient.

Detailed description

Background: Post stroke Scapular dyskinesia leads to scapulohumeral pain \& dysfunction were associated with decreased motor function, somatosensory function, limited range of motion, and spasticity. Objective: to investigate the effect of Scapular dyskinesia on the scapular balance angle \& upper extremity Sensorimotor Function in spastic stroke patient. Methods: sixty patients from both sexes were participated in this study. All the patients were diagnosed as spastic stroke patients. The patients were divided into two equal groups; group A (30 patients): with high scapular dyskinesia scores, group B (30 patients): with low or no scapular dyskinesia scores. The patients were diagnosed with the Lateral scapular slide test using Palpation meter (PALM) device, Fugl-Meyer upper extremity (FMUE) Scale scores \& scapular balance angle test (SBA).

Conditions

Interventions

TypeNameDescription
OTHERAssessment of scapular balance angle and upper extremity sensorimotor functionThe patients were diagnosed with the Lateral scapular slide test using Palpation meter (PALM) device, Fugl-Meyer upper extremity (FMUE) Scale scores \& scapular balance angle test (SBA).

Timeline

Start date
2019-03-01
Primary completion
2019-06-05
Completion
2019-06-05
First posted
2019-07-02
Last updated
2020-08-27

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04004949. Inclusion in this directory is not an endorsement.